Wednesday, January 26, 2011

PHARMA PAYING THE PRICE

(Reuters) - Europe's drive to cut drug prices as well as U.S. healthcare reforms are likely to dampen global pharmaceutical companies' growth outlooks for 2011. Reuters 

No comments:

Post a Comment

ShareThis

Become A Fan

Tweet